

This center treats substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
Provides 24/7 medical supervision and intensive treatment in a clinical setting for individuals in crisis or with acute needs, focusing on stabilization and immediate safety
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center treats substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
Provides 24/7 medical supervision and intensive treatment in a clinical setting for individuals in crisis or with acute needs, focusing on stabilization and immediate safety
The Trillium Place team will work with you to explore the right payment options based on your needs, ensuring you get the best possible treatment.
Trillium Place Crisis Center in Peoria, Illinois, offers comprehensive mental health services for adults experiencing crises related to conditions such as depression, anxiety, mood disorders, substance use, and trauma. Their 24/7 crisis intervention includes immediate evaluation, counseling, medically monitored detox, and referrals to appropriate care levels, helping ensure timely support for individuals in distress.
A standout feature of the center is "The Living Room," a walk-in program offering a safe, supportive environment where individuals can engage with certified recovery specialists for crisis support, safety planning, and goal setting. This initiative emphasizes peer support and immediate access to care without appointments, fostering a welcoming atmosphere for those seeking help. By integrating professional services with peer-led support, Trillium Place Crisis Center addresses urgent mental health needs, promoting stabilization and connection to ongoing resources.
This center treats substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
The Joint Commission accreditation is a voluntary, objective process that evaluates and accredits healthcare organizations (like treatment centers) based on performance standards designed to improve quality and safety for patients. To be accredited means the treatment center has been found to meet the Commission's standards for quality and safety in patient care.

Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT

Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.

Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.

Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.